Showing results (151-160 of 255) with videos related to

Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry|October 17, 2020
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linkerBridget Duvall, Sarah C Zimmermann, Run-Duo Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in GlioblastomaBachchu Lal, Aditya Kulkarni, Joseph McDermott, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 18, 2018
Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effectsZhi-Bing You, Guo-Hua Bi, Ewa Galaj, et al.
Journal of Alzheimer'S Disease : JAD|July 18, 2020
Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 MiceKristen R Hollinger, Xiaolei Zhu, Elizabeth S Khoury, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2018
Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney diseaseIrfana Soomro, Ying Sun, Zhai Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2023
Neutral sphingomyelinase 2 is required for HIV-1 maturationAbdul A Waheed, Yanan Zhu, Eva Agostino, et al.
Journal of Extracellular Vesicles|January 7, 2021
Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APPZhigang Li, Mohammed Moniruzzaman, Raha M Dastgheyb, et al.
JCI Insight|May 11, 2023
T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockadeKyungho Lee, Elizabeth A Thompson, Sepideh Gharaie, et al.
Pageof 26